Stay updated on FG-3019 in Hepatitis B Liver Fibrosis Clinical Trial
Sign up to get notified when there's something new on the FG-3019 in Hepatitis B Liver Fibrosis Clinical Trial page.

Latest updates to the FG-3019 in Hepatitis B Liver Fibrosis Clinical Trial page
- Check7 days agoChange DetectedThe page has been updated to reflect a new version (v2.15.0) and the title has been changed to 'Liver Fibrosis Due to Chronic Hepatitis B Infection'. Significant details regarding the study's goals, criteria, and investigators have been removed.SummaryDifference18%
- Check15 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check22 days agoNo Change Detected
- Check29 days agoNo Change Detected
- Check58 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check72 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference2%
- Check80 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
- Check94 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
Stay in the know with updates to FG-3019 in Hepatitis B Liver Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FG-3019 in Hepatitis B Liver Fibrosis Clinical Trial page.